The role of enteric hormone GLP-2 in the response of bone markers to a mixed meal in postmenopausal women with type 2 diabetes mellitus
详细信息    查看全文
  • 作者:Laura S Gir?o Lopes ; Rubens Prado Schwartz…
  • 关键词:Bone remodeling ; Type 2 diabetes mellitus ; Mixed meal ; GLP ; 2 ; CTX ; Osteocalcin
  • 刊名:Diabetology and Metabolic Syndrome
  • 出版年:2015
  • 出版时间:December 2015
  • 年:2015
  • 卷:7
  • 期:1
  • 全文大小:618 KB
  • 参考文献:1. Melton, LJ, Leibson, CL, Achenbach, SJ, Therneau, TM, Khosla, S (2008) Fracture risk in type 2 diabetes: update of a population-based study. J Bone Miner Res 23: pp. 1334-42 CrossRef
    2. Janghorbani, M, Dam, RM, Willett, WC, Hu, FB (2007) Systematic review of type 1 and type 2 diabetes mellitus and risk of fracture. Am J Epidemiol 166: pp. 495-505 CrossRef
    3. Yamamoto, M, Yamaguchi, T, Yamauchi, M, Kaji, H, Sugimoto, T (2009) Diabetic patients have an increased risk of vertebral fractures independent of BMD or diabetic complications. J Bone Miner Res 24: pp. 702-9 CrossRef
    4. de Liefde, II, Klift, M, Laet, CE, Daele, PL, Hofman, A, Pols, HA (2005) Bone mineral density and fracture risk in type-2 diabetes mellitus: the Rotterdam Study. Osteoporos Int 16: pp. 1713-20 CrossRef
    5. Ma, L, Oei, L, Jiang, L, Estrada, K, Chen, H, Wang, Z (2012) Association between bone mineral density and type 2 diabetes mellitus: a meta-analysis of observational studies. Eur J Epidemiol 27: pp. 319-32 CrossRef
    6. Moseley, KF (2012) Type 2 diabetes and bone fractures. Curr Opin Endocrinol Diabetes Obes 19: pp. 128-35 CrossRef
    7. Lee, J, Vasikaran, S (2012) Current recommendations for laboratory testing and use of bone turnover markers in management of osteoporosis. Ann Lab Med 32: pp. 105-12 CrossRef
    8. Brown, JP, Albert, C, Nassar, BA, Adachi, JD, Cole, D, Davison, KS (2009) Bone turnover markers in the management of postmenopausal osteoporosis. Clin Biochem 42: pp. 929-42 CrossRef
    9. Bjarnason, NH, Henriksen, EE, Alexandersen, P, Christgau, S, Henriksen, DB, Christiansen, C (2002) Mechanism of circadian variation in bone resorption. Bone 30: pp. 307-13 CrossRef
    10. Walsh, JS, Henriksen, DB (2010) Feeding and bone. Arch Biochem Biophys 503: pp. 11-9 CrossRef
    11. Clowes, JA, Allen, HC, Prentis, DM, Eastell, R, Blumsohn, A (2003) Octreotide abolishes the acute decrease in bone turnover in response to oral glucose. J Clin Endocrinol Metab 88: pp. 4867-73 CrossRef
    12. Henriksen, DB, Alexandersen, P, Bjarnason, NH, Vilsboll, T, Hartmann, B, Henriksen, EE (2003) Role of gastrointestinal hormones in postprandial reduction of bone resorption. J Bone Miner Res 18: pp. 2180-9 CrossRef
    13. Pietschmann, P, Resch, H, Woloszczuk, W, Willvonseder, R (1990) A circadian rhythm of serum osteocalcin levels in postmenopausal osteoporosis. Eur J Clin Invest 20: pp. 310-2 CrossRef
    14. Gottschalck, IB, Jeppesen, PB, Hartmann, B, Holst, JJ, Henriksen, DB (2008) Effects of treatment with glucagon-like peptide-2 on bone resorption in colectomized patients with distal ileostomy or jejunostomy and short-bowel syndrome. Scand J Gastroenterol 43: pp. 1304-10 CrossRef
    15. Ducy, P (2011) The role of osteocalcin in the endocrine cross-talk between bone remodelling and energy metabolism. Diabetologia 54: pp. 1291-7 CrossRef
    16. Yazbeck, R, Howarth, GS, Abbott, CA (2009) Growth factor based therapies and intestinal disease: is glucagon-like peptide-2 the new way forward?. Cytokine Growth Factor Rev 20: pp. 175-84
  • 刊物主题:Diabetes; Metabolic Diseases; Endocrinology;
  • 出版者:BioMed Central
  • ISSN:1758-5996
文摘
Background Type 2 diabetes mellitus (T2D) is a complex disease associated with several chronic complications, including bone fragility and high fracture risk due to mechanisms not yet fully understood. The influence of the gastrointestinal tract and its hormones on bone remodeling has been demonstrated in healthy individuals. Glucagon-like peptide 2 (GLP-2), an enteric hormone secreted in response to nutrient intake, has been implicated as a mediator of nutrient effects on bone remodeling. This study aimed to analyze the dynamics of bone resorption marker C-terminal telopeptide of type I collagen (CTX), bone formation marker osteocalcin, and GLP-2 in response to a mixed meal in diabetic postmenopausal women. Methods Forty-three postmenopausal women with osteopenia or osteoporosis (20 controls -group CO -and 23 diabetic -group T2D) were subjected to a standard mixed meal tolerance test, with determination of serum CTX, plasma osteocalcin and serum GLP-2 concentrations at baseline and 30, 60, 120 and 180?minutes after the meal. Results T2D women had higher body mass index as well as higher femoral neck and total hip bone mineral density. At baseline, luteinizing hormone, follicle-stimulating hormone, osteocalcin and CTX levels were lower in group T2D. In response to the mixed meal, CTX and osteocalcin levels decreased and GLP-2 levels increased in both groups. The expected CTX suppression in response to the mixed meal was lower in group T2D. Conclusions Bone turnover markers were significantly reduced in T2D women at baseline. Confirming the role of nutrient intake as a stimulating factor, GLP-2 increased in response to the mixed meal in both groups. Importantly, CTX variation in response to the mixed meal was reduced in T2D women, suggesting abnormal response of bone remodeling to nutrient intake in T2D.

© 2004-2018 中国地质图书馆版权所有 京ICP备05064691号 京公网安备11010802017129号

地址:北京市海淀区学院路29号 邮编:100083

电话:办公室:(+86 10)66554848;文献借阅、咨询服务、科技查新:66554700